Aquestive Therapeutics (AQST) Interest Coverage Ratio (2017 - 2026)

Aquestive Therapeutics' Interest Coverage Ratio history runs 10 years deep, the most recent figure standing at 0.57 for Q1 2026.

• On a quarterly basis, Interest Coverage Ratio rose 74.51% year-over-year to 0.57 in Q1 2026; TTM through Mar 2026 was 7.52, a 59.34% decrease from a year earlier, with the FY2025 full-year figure at 0.63, down 92.91% from the prior year.
• Interest Coverage Ratio declined to 0.57 in Q1 2026 per AQST's latest filing, from 12.85 in the prior quarter.
• Across five years, Interest Coverage Ratio topped out at 12.85 in Q4 2025 and bottomed at 6.49 in Q4 2022.
• The 5-year median for Interest Coverage Ratio is 0.91 (2024), against an average of 0.89.
• Biggest YoY gain for Interest Coverage Ratio was 609.26% in 2025; the steepest drop was 23879.54% in 2025.
• Year by year, Interest Coverage Ratio stood at 6.49 in 2022, then soared by 66.06% to 2.2 in 2023, then surged by 182.24% to 1.81 in 2024, then jumped by 609.26% to 12.85 in 2025, then sank by 104.4% to 0.57 in 2026.
• Per Business Quant, the three latest AQST Interest Coverage Ratio figures stand at 0.57 (Q1 2026), 12.85 (Q4 2025), and 3.86 (Q3 2025).